Clene preparing for upcoming meeting in the second quarter with the U.S. Food and Drug Administration (FDA) to reach agreement…
- End-of-Phase 2 meeting with FDA requested for Alzheimer’s disease - - Phase 2 results in dementia with Lewy bodies accepted for oral…
Leveraging the Power of Data to Accelerate Scientific Discovery and Improve Health in the Bronx NEW YORK, May 6, 2025…
University of Wisconsin–Madison Research Project Will Investigate Whether Transcranial Electrical Stimulation with Temporal Interference Can Improve the Restorative Nature of…
Presentation of biomarker findings from cerebrospinal fluid analysesWorkshop on adaptive and decentralized ALS trial designPanel on clinical trial access and the…
SAN MATEO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated…
Annamycin has the potential to be safer and more effective than current prescribed anthracyclines to treat serious, hard-to-treat cancers Ongoing…
SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty…
VALBY, Denmark, May 6, 2025 /PRNewswire/ -- H. Lundbeck A/S is pleased to announce its agreement with the Danish Centre for AI…
Company continues to expand global IP coverage and claims to major markets, now extending to June 2040 HOUSTON, May 05,…
